Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alkermes Plc (NQ: ALKS )

19.02 USD -0.03 (-0.16%)
Official Closing Price Updated: 5:20 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Alkermes Plc

< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
Notable Friday Option Activity: ALKS, FND, NOC
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Alkermes plc (ALKS), where a total of 7,910 contracts have traded so far, representing... 
Tags Stocks
From Market News Video
How Posting About Alcohol May Be Hurting Those Having Trouble Coping With the Pandemic
Tags Chronic Illness pandemic NASDAQ:ALKS
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Celebrates World Health Day 2021
Tags Events, Media & Communications NASDAQ:ALKS Good Health and Well/Being
From 3BL Media: Corporate Social Responsibility, Energy and Health News
The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags OM MGNX GLTO
From Benzinga
Alkermes Announces Clinical Trial Collaboration and Supply Agreement With MSD to Evaluate Nemvaleukin Alfa in Combination With KEYTRUDA® in Patients With Platinum-Resistant Ovarian Cancer
Alkermes plc (Nasdaq: ALKS) today announced that it has entered into a clinical trial collaboration and supply agreement with MSD (a tradename of Merck & Co., Inc. Kenilworth, NJ, USA) for a planned... 
From PR Newswire
Alkermes Employee Reflects on His Family's Experience with Cancer and How It Impacts His Work
Tags Life Science Alkermes Employee Engagement
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Celebrates National Cancer Control Month
Tags Disease Awareness Healthcare Innovation Health & Healthcare
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes + Mental Health Missions
Tags Wellness Health & Healthcare Responsible Business & Employee Engagement
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Kicks Off Alcohol Awareness Month
Tags Health & Healthcare Wellness NASDAQ:ALKS
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes & MD Edge Psych Podcast Discuss Living With Schizophrenia
Tags Health & Healthcare Disease Awareness Continuing Education
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Commits to Being #BipolarBrave on World Bipolar Day
Tags Good Health and Well/Being NASDAQ:ALKS Responsible Business & Employee Engagement
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Provides Tips on Talking to a Doctor About Your Mental Health
Tags NASDAQ:ALKS Good Health and Well/Being Wellness
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes to Take Part in Stifel's 3rd Annual CNS Day
Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at Stifel's 3rd Annual CNS Day on Thursday, Apr. 1, 2021 at 8:30 a.m. ET (1:30 p.m. BST). The... 
From PR Newswire
Alkermes Investor Day to Focus on Scientific Progress and Value Creation Strategy
- Company Will Provide New Updates and Disclose New Programs in Neuroscience and Oncology Development Pipeline- 
From PR Newswire
Alkermes Celebrates Female Oncology Pioneer in Honor of Women’s History Month
Tags Education Dr/ Mary/Claire King Alkermes
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Celebrates Brain Awareness Week
Tags Disease Awareness brain awareness week Research & Policy
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Employee Strives to Make a Difference in Cancer Patients' Lives
Tags Responsible Business & Employee Engagement Health & Healthcare Good Health and Well/Being
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes: How Substance Use Disorder Changes the Brain
Tags Disease Awareness Health & Healthcare Healthcare Industry News
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes VP of Marketing Shares What Inspires His Work
Tags Ethics & Governance Corporate Social Responsibility Disease Awareness
From 3BL Media: Corporate Social Responsibility, Energy and Health News
The Implied Analyst 12-Month Target For FNY
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Alkermes Encourages You to Reach Out to Provide Support for Those Suffering From Alcohol Use Disorder
Tags Pharma News, Research & Solutions NASDAQ:ALKS Good Health and Well/Being
From 3BL Media: Corporate Social Responsibility, Energy and Health News
The Daily Biotech Pulse: Contrasting COVID-19 Treatment Readouts From Roche, Vir, Delay In Kadmon's FDA Review, Alzheimer's Data From Prothena
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BTAI BCAB Earnings
From Benzinga
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
Alkermes plc (Nasdaq: ALKS) today announced that nemvaleukin alfa ("nemvaleukin", formerly referred to as ALKS 4230), the company's investigational engineered interleukin-2 (IL-2) variant... 
From PR Newswire
Alkermes Provides Information and Resources About Telepsych
Tags Alkermes Improving Healthcare Access Mental Health
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Lyra Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update
Lyra Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results, Provides Corporate Update 
From Business Wire News Releases
Alkermes Employee Shares How Her Experience With Bipolar Disorder Inspires Her at Work
Tags Disease Awareness Health & Healthcare Responsible Business & Employee Engagement
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Provides Resources for Those Experiencing Substance Use Disorder and Isolation During the Pandemic
Tags Wellness substance use disorder Health & Healthcare
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes to Hold Virtual Investor Day
Alkermes plc (Nasdaq: ALKS) announced today that it will hold a virtual Investor Day on Thursday, March 25, 2021, beginning at 9:00 a.m. ET (1:00 p.m. GMT). During the event, members of Alkermes'... 
From PR Newswire
Alkermes Shares Tips for Preventing Cancer and Spreading Awareness
Tags Pharma News, Research & Solutions NASDAQ:ALKS Immunotherapy
From 3BL Media: Corporate Social Responsibility, Energy and Health News
How Does Schizophrenia Affect the Brain?
Tags Alkermes Chronic Illness Life Science
From 3BL Media: Corporate Social Responsibility, Energy and Health News
< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.